top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants

  • Dec 30, 2024
  • 1 min read

Germantown, MD, December 27, 2024 (PRNewswire) -- Precigen, Inc. has entered into a securities purchase agreement for the sale of its 8.00% Series A Convertible Perpetual Preferred Stock in a private placement, raising $79 million in gross proceeds. The transaction also includes warrants allowing investors to purchase up to 52.67 million shares of Precigen's common stock at $0.75 per share. The offering is expected to close by December 30, 2024, subject to customary conditions.


Read full article here.

 
 
 

Recent Posts

See All
ImpediMed Appoints Erik Anderson as CEO

Brisbane, CA, April 7, 2026 (ImpediMed) — ImpediMed has named Erik Anderson as its new chief executive officer. The leadership change is intended to guide the company’s strategic direction and support

 
 
 

Comments


Life Science Headlines
bottom of page